J&J looks for gesture for COVID-19 vaccine trials for 12-17 age group in India
American pharma goliath Johnson and Johnson (J&J) has moved an application to the Central Drugs Standard Control Organization (CDSCO) looking for authorization to direct an investigation of the COVID-19 single shot Janssen immunization in India in youths matured 12 – 17 years. The single-shot antibody, created by J&J demonstrated to be 85% viability in forestalling […]